CNS Pharmaceuticals, Inc.
(NASDAQ : CNSP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.06%178.250.7%$1351.40m
MRKMerck & Co., Inc. 1.55%94.080.7%$1230.78m
PFEPfizer Inc. 1.49%52.410.9%$1111.50m
LLYEli Lilly & Co. 1.16%330.971.1%$1038.05m
BMYBristol-Myers Squibb Co. 0.82%76.581.0%$999.60m
ABBVAbbVie, Inc. 0.10%154.081.9%$961.16m
AZNAstraZeneca Plc 0.81%66.041.0%$474.77m
SGENSeagen Inc. -0.66%175.605.7%$323.90m
GSKGSK Plc -0.24%43.200.2%$271.76m
TPTXTurning Point Therapeutics, Inc. -0.14%75.050.0%$199.01m
HZNPHorizon Therapeutics Plc -0.66%82.225.4%$172.95m
NVSNovartis AG -0.94%83.490.2%$170.65m
MRTXMirati Therapeutics, Inc. 1.25%72.861.6%$152.70m
ALNYAlnylam Pharmaceuticals, Inc. -0.68%149.718.1%$149.29m
NVONovo Nordisk A/S -1.02%110.110.1%$146.86m

Company Profile

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.